Navigation Links
Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
Date:10/15/2008

/p>

Significant Q3 2008 transactions and events

The commercial launch of ORALAIR(R) Grasses for adults took place in Germany at the end of July. The product was well received by allergy professionals. However, ORALAIR(R) Grasses' sales over the quarter were not significant since the launch occurred after the pollen season.

The marketing licence of ORALAIR(R) Grasses in its paediatric indication, which should be delivered by the German agency before the end of the year, will mark the start of the European mutual recognition registration procedure of the product.

The roll-out of the ORALAIR(R) Mites phase II/III pivotal study, initiated at the end of 2007, is continuing satisfactorily.

Lastly, Stallergenes expanded its product range following the exclusive agreement announced on 7 October for the promotion and distribution in Europe of an adrenalin auto-injector, jointly developed and manufactured by Catalent and The Medical House PLC.

Outlook for the current financial year

Due to the strong sales recorded over the quarter, the Company is in a position, for the second time this year, to review its 2008 full-year sales guidance upwards. Sales growth in the region of 14% is now expected.

As a result, at the same time as implementing a significant research and development expenditure programme, the Group's guidance is for full-year net profit slightly higher than in the previous financial year, as well as a further improved financial position, which will enhance its development resources.

About Stallergenes

Stallergenes is a European biopharmaceutical company dedicated to desensitisation therapies for the prevention and treatment of allergy-related respiratory diseases, e.g. rhino-conjunctivitis and allergic asthma. A pioneer and leader in sublingual desensitisation treatment, Stallergenes devotes 20% in raw data of its sales to Research and Development and is actively involved in the development of a new t
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
2. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
3. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
4. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
5. Newly Integrated Software Suite From ZS Associates Offers Comprehensive Set of Sales Performance Management Software Solutions
6. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
7. Guillermo Moreno Named Aurillions Vice President of Sales and Marketing
8. Genstruct Names Louis Latino VP of Sales
9. BioElectronics Corp Aggressively Expands Sales into Middle East
10. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
11. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 Local veterinary surgeon, ... an investigational study of donor stem cells for dogs ... cell therapy and has performed clinical stem cell therapy ... is to determine if a single injection of donor ... can help reduce pain and inflammation in the treated ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
(Date:10/19/2014)... The Asian Orthopedic braces and support systems ... analysis and forecast of revenue. The Orthopedic braces and support ... $416.5 million by 2018, at a developing CAGR of 4.4% ... the Asian Orthopedic braces and support systems market, to get ... a glimpse of the segmentation of orthopedic braces and support ...
(Date:10/18/2014)... 2014 The Asia-Pacific Bio-based Advanced ... the bio-based advanced phase change material market in ... Browse through the TOC of the Asia-Pacific Bio-based ... an idea of the in-depth analysis provided. This ... the Asia-Pacific bio-based advanced phase change material market, ...
Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4
... Georgetown experts to address biotechnology, science, policy and ethical issues ... WASHINGTON , ... and the Food and Drug Administration outlined a "path " to ... to match a person,s genetic make-up.  Significant progress in this rapidly developing ...
... ... Sensor Foundry , ... 22, 2010 -- Forza Silicon Corporation announced today that it is in a joint development ... high dynamic range CMOS image sensors., , , , ,Forza Silicon Corporation Chief Technology Officer, ...
... ... Corporate Sustainability Report. , ... Madison, WI USA (PRWEB) June 22, 2010 -- Promega reports significant reductions in ... Promega goals and accomplishments to conserve natural resources, minimize environmental impacts and demonstrate global ...
Cached Biology Technology:Pebbles Along the 'Path' to Personalized Medicine 2Pebbles Along the 'Path' to Personalized Medicine 3Pebbles Along the 'Path' to Personalized Medicine 4Forza Silicon Announces High Dynamic Range CMOS Sensor Development 2Promega Releases 2009 Corporate Sustainability Report 2
(Date:10/14/2014)... A Mount Sinai-led research team has discovered a new kind ... or a cell that lines liver blood vessels, according to ... Reports . The existence of such a cell type contradicts ... the embryo, and may hold clues to origins of, and ... develop from a single cell into a complex being made ...
(Date:10/14/2014)... – A team of scientists led by researchers ... and the University of Miami Miller School of ... key genetic pathway underlying bipolar (manic depressive) disorder, ... for treating bipolar affective disorder, as well as ... new findings, published online this week in Nature ...
(Date:10/14/2014)... PA, October 14, 2014 – Over the past decades, ... of institutions to meet the needs of infants for ... of these infants to thrive. , Infancy ... development of the cortex. A generation of research suggests ... promote cortical development and cognitive function. In contrast, deprivation ...
Breaking Biology News(10 mins):Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3Institutional rearing may increase risk attention-deficit disorder 2
... clear skies and smooth sailing for oceanic vessels has ... to air pollution and greenhouse gas emissions that impact ... James Winebrake and James Corbett examines "Emission Tradeoffs among ... Oil, Marine Gas Oil, and Marine Diesel Oil," in ...
... The 2009 Force Protection Equipment,Demonstration (FPED VII) will ... and Marine Corps Base, Quantico, VA, next May ... War on Terror., The demonstration is the ... commercial off-the-shelf equipment solutions to current,and evolving force ...
... new paper by a team of researchers led by ... the University of Notre Dame, provides important new insights ... wall. The cell wall is a critically important ... is a rigid entity encasing the bacterium, and antibiotics ...
Cached Biology News:Fuel emissions from marine vessels remain a global concern 22009 Force Protection Equipment Demonstration Set for Next May 19-21 2
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
... for 2-D separations. The cell has a six-gel ... xi multi-cell can be customized for several parameters: ... cooling system. The PROTEAN II xi multi-cell can ... multi-cell for a wider format that accommodates 17 ...
... 16 cm, is used for vertical slab gel ... gels. The cell is supplied without spacers and ... with gaskets, lower buffer chamber, lid with cables, ... upper buffer dam, casting stand with gaskets, leveling ...
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
Biology Products: